EGFR and renal cell carcinoma: In conjunction with the aforementioned findings, our results demonstrated that through inhibiting the EGFR–MEK–ERK signaling pathway, CTSC and CTSV expression are involved in Pra-B’s suppression of EGF-induced migration and invasion in RCC cells.